A new study using mass spectrometry is helping piece together what happens when DNA that has been sensitized by the oncology drug 5-fluorouracil is subjected to the ionising radiation used in radiotherapy.
Cancer treatment often involves a combination of chemotherapy and radiotherapy. Chemotherapy uses medication to stop cancer cells reproducing, but the medication affects the entire body. Radiotherapy uses radiation to kill ...
Theranostics is an emerging field of medicine whose name is a combination of "therapeutics" and "diagnostics." The idea behind theranostics is to combine drugs and/or techniques to simultaneously—or sequentially—diagnose ...
The RAS oncogene is activated in 30 percent of human cancers, and results in the proliferation and transformation of tumor cells. No effective inhibitor has been found for this protein to date.
Particle beam therapy is increasingly being used to treat many types of cancer. It consists in subjecting tumours to beams of high-energy charged particles such as protons. Although more targeted than conventional radiotherapy ...
Organ-on-a-chip technology is being used to develop 3-D models that allow researchers in South Australia to investigate the impact of radiotherapy on the body's tissues.
Measuring a fever is usually pretty simple: place a thermometer under a patient's tongue and get an accurate temperature reading within 30 seconds. But that simplicity does not translate when it comes to measuring the temperatures ...
Researchers at the National Institute of Standards and Technology (NIST) have published landmark test results that suggest a promising class of sensors can be used in high-radiation environments and to advance important medical, ...
In November 2017, a Titan Krios cryo-electron microscope (cryo-EM) was inaugurated at the ESRF, the European Synchrotron, France. Data collected on this cryo-EM features in a Nature publication describing the activation cycle ...
Antibody-based imaging of a particularly aggressive form of breast cancer is undergoing clinical trials worldwide, but the path from trial to application is being hampered by a major obstacle: safety.
